Patents by Inventor Christine Brunn Schioedt

Christine Brunn Schioedt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable growth hormone compounds resistant to proteolytic degradation
    Patent number: 9211342
    Abstract: The present invention relates to growth hormone (GH) compounds having additional disulphide bridges and at least one additional single point mutation making the compounds resistant to proteolytic degradation.
    Type: Grant
    Filed: January 24, 2011
    Date of Patent: December 15, 2015
    Assignee: NOVO NORDISK HEALTHCARE AG
    Inventors: Helle Demuth, Christine Brunn Schioedt, Leif Noerskov-Lauritsen, Jianhe Chen, Peter Thygesen
  • STABLE GROWTH HORMONE COMPOUNDS
    Publication number: 20130040883
    Abstract: The present invention relates to growth hormone (GH) compounds having additional disulphide bridges and at least one additional single point mutation making the compounds resistant to proteolytic degradation.
    Type: Application
    Filed: January 24, 2011
    Publication date: February 14, 2013
    Applicant: Novo Nordisk HealthCare AG
    Inventors: Helle Demuth, Christine Brunn Schioedt, Leif Noerskov-Lauritsen, Jianhe Chen, Peter Thygesen